OverviewChartProfileKey statisticsFinancialsTechnicalNews
Derivatives
TraderScreen

ROCHE I/  CH0012032113  /

SIX Swiss Exchange
10/07/2024  17:13:05 Chg. +5.20 Volume Bid17:14:14 Ask17:14:14 Market Capitalization Dividend Y. P/E Ratio
277.20CHF +1.91% 13,535
Turnover: 3.71 mill.		 277.00Bid Size: 223 277.40Ask Size: 307 231.58 bill.CHF 3.43% 19.21
Newsfile Corp 14:30 First Phosphate confirme le plus long intervalle à haute teneur à ce jour de 8,9 % de phosphate igné...
GlobeNewswire 27/06 Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product
GlobeNewswire 18/06 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 14/06 LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon...
GlobeNewswire 11/06 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
TeleTrader 27/05 Roche shuffles its executive committee
TeleTrader 16/05 Roche notes progress in obesity drug trial
GlobeNewswire 09/05 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 07/05 Enable Injections Expands Strategic Partnership with Roche
TeleTrader 24/04 Roche's logs 14.4 billion Swiss francs in Q1 sales
GlobeNewswire 03/04 UHN Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Inju...
GlobeNewswire 02/04 Arch Biopartners Adds Three New Clinical Sites into the Phase II Trial for LSALT Peptide Targeting C...
GlobeNewswire 01/04 AssetMark Honors Financial Advisors with Community Inspiration Award
GlobeNewswire 22/03 HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highl...
GlobeNewswire 14/03 Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides C...
GlobeNewswire 26/02 Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Ro...
GlobeNewswire 21/02 REPARE ALERT: Bragar Eagel & Squire, P.C. is Investigating Repare Therapeutics Inc. on Behalf of Rep...
GlobeNewswire 13/02 Roivant Reports Financial Results for the Third Quarter Ended December 31, 2023, and Provides Busine...
GlobeNewswire 08/02 Accumulus Synergy Launches Highly Anticipated Cloud-Based Platform
TeleTrader 01/02 Roche's 2023 sales increase 1% to 58.7B Swiss francs
GlobeNewswire 30/01 COUR Pharmaceuticals Secures $105 Million in Series A Financing Co-Led by Lumira Ventures and Alpha ...
GlobeNewswire 29/01 Carmot Therapeutics Announces Completion of Acquisition by Roche
GlobeNewswire 03/01 US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Haltin...
GlobeNewswire 03/01 Arch Biopartners Receives Approval from the Turkish Ministry of Health to Proceed with Phase II Tria...
GlobeNewswire 29/12/2023 LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche